Skip to Content

Eptifibatide Injection

Last Updated: August 11, 2016
Status: Current

Products Affected - Description

All presentations are currently available

Reason for the Shortage

  • Merck states the reason for the shortage was manufacturing delay.
  • AuroMedics launched eptifibatide injection in December 2015.

Available Products

Integrilin injection, Merck
0.75 mg/mL, 100 mL vial, 1 count (NDC 00085-1136-01)

2 mg/mL, 10 mL vial, 1 count (NDC 00085-1177-01)
2 mg/mL, 100 mL vial, 1 count (NDC 00085-1177-02)
 
Eptifibatide injection, AuroMedics
0.75 mg/mL, 100 mL vial, 1 count (NDC 55150-0218-99)
2 mg/mL, 10 mL vial, 1 count (NDC 55150-0219-10)
2 mg/mL, 100 mL vial, 1 count (NDC 55150-0220-99)

Estimated Resupply Dates

All marketed presentations are available.

Related Shortages

Updated

August 11, July 21, May 16, April 6, March 15, February 4, January 28, 2016; December 29, 22 and 1, October 28 and 8, September 23, 2015, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide